Company intelligence / Profile preview

Nutrigenomics

Toronto, Ontario, Canada

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Nutrigenomix is a biotechnology company specializing in personalized nutrition through genetic testing. Founded as a spin-off from the University of Toronto, the company provides evidence-based genomic tools to healthcare professionals to help tailor dietary recommendations to an individual's genetic profile. Their core product is a saliva-based DNA test that analyzes genetic variants related to nutrient metabolism, food intolerances, and chronic disease risk. By bridging the gap between genomic science and clinical nutrition, Nutrigenomix enables practitioners to deliver highly targeted wellness and performance plans.

Therapeutic areas: EndocrinologyOtherMetabolic DisordersWomen's Health
Modalities: Genetic testingNutraceuticals
Industry: Molecular Diagnostics

Partnerships

University of TorontoCleveland Clinic

Beyond the preview

Go deeper on Nutrigenomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrigenomics.

Explore the full profile